About
Passionate about lifesciences and the potential of its innovations to improve the lives…
Activity
-
Heel trots op deze gezamenlijke reis, Loïc. Jullie werk stimuleert ons bij vdk bank om voluit verder te investeren in het mooiste impactproject…
Heel trots op deze gezamenlijke reis, Loïc. Jullie werk stimuleert ons bij vdk bank om voluit verder te investeren in het mooiste impactproject…
Liked by Caroline Goddeeris
-
Exciting News! Tubulis is one of Fierce Biotech’s 2024 #Fierce15 #biotech companies! Being selected for this prestigious industry award is an…
Exciting News! Tubulis is one of Fierce Biotech’s 2024 #Fierce15 #biotech companies! Being selected for this prestigious industry award is an…
Liked by Caroline Goddeeris
-
Great to have been working on this one together with our excellent team!
Great to have been working on this one together with our excellent team!
Liked by Caroline Goddeeris
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
-
Vlerick Business School
-
-
-
-
-
Greatest Distinction
Awarded 'Best Student' by the Vlerick Alumni.
Student Representative -
-
Study of physicochemical properties of smedds and solid dispersions containing poorly water soluble drugs
Received the 2008 AAPS Graduate Student Award for Lipid Drug Delivery Research -
-
Great Distinction
More activity by Caroline
-
The Fund+ Portfolio Company Confo Therapeutics Announces EUR 60M Series B Financing to Advance Pipeline of Novel GPCR-Modulating Therapies into…
The Fund+ Portfolio Company Confo Therapeutics Announces EUR 60M Series B Financing to Advance Pipeline of Novel GPCR-Modulating Therapies into…
Liked by Caroline Goddeeris
-
🌟 Join Us for an Evening of Networking, Insights, and Celebration! 🌟 We are thrilled to invite you to the Level 20 Belgium Annual Reception at the…
🌟 Join Us for an Evening of Networking, Insights, and Celebration! 🌟 We are thrilled to invite you to the Level 20 Belgium Annual Reception at the…
Liked by Caroline Goddeeris
-
Are agonistic antibodies the future of GPCR modulation? 👀 After CatalYm GmbH’s $150 million and Asceneuron SA’s $100 million rounds, it’s Confo…
Are agonistic antibodies the future of GPCR modulation? 👀 After CatalYm GmbH’s $150 million and Asceneuron SA’s $100 million rounds, it’s Confo…
Liked by Caroline Goddeeris
-
📢 Giving a commercial voice to the pipeline is how Natalia Borniquel, VP of New Product Planning (NPP) at Lundbeck, describes her job. Curious about…
📢 Giving a commercial voice to the pipeline is how Natalia Borniquel, VP of New Product Planning (NPP) at Lundbeck, describes her job. Curious about…
Liked by Caroline Goddeeris
-
I’m usually not one to share personal milestones on social media, but today marks a significant occasion. My mandate as CEO of Proximus Group has…
I’m usually not one to share personal milestones on social media, but today marks a significant occasion. My mandate as CEO of Proximus Group has…
Liked by Caroline Goddeeris
-
Our second quarter earnings report is now available. This quarter, we’ve made notable strides on the path toward Vision 2030 – reaching 50,000…
Our second quarter earnings report is now available. This quarter, we’ve made notable strides on the path toward Vision 2030 – reaching 50,000…
Liked by Caroline Goddeeris
-
🙌 📢 Andera Partners 𝐂𝐨-𝐋𝐞𝐚𝐝𝐬 $𝟏𝟗𝟔 𝐌𝐢𝐥𝐥𝐢𝐨𝐧 𝐑𝐨𝐮𝐧𝐝 for Kestra Medical Technologies, Inc. and Welcomes Raymond W. Cohen to Board…
🙌 📢 Andera Partners 𝐂𝐨-𝐋𝐞𝐚𝐝𝐬 $𝟏𝟗𝟔 𝐌𝐢𝐥𝐥𝐢𝐨𝐧 𝐑𝐨𝐮𝐧𝐝 for Kestra Medical Technologies, Inc. and Welcomes Raymond W. Cohen to Board…
Liked by Caroline Goddeeris
-
#fundingalert 💼Company: Confo Therapeutics 💰Funding: €60Million ⚡Round: Series B 👥Investors: Ackermans & van Haaren(AvH), Driehaus Capital…
#fundingalert 💼Company: Confo Therapeutics 💰Funding: €60Million ⚡Round: Series B 👥Investors: Ackermans & van Haaren(AvH), Driehaus Capital…
Liked by Caroline Goddeeris
-
Confo Therapeutics rondde zonet een Serie B-financiering van 60 miljoen euro af waarmee het o.a. klinische studies wil starten voor twee programma's,…
Confo Therapeutics rondde zonet een Serie B-financiering van 60 miljoen euro af waarmee het o.a. klinische studies wil starten voor twee programma's,…
Liked by Caroline Goddeeris
-
BGV (BioGeneration Ventures) portfolio company Brenig Therapeutics closed a $65 million Series A financing round led by NEA, with support from an…
BGV (BioGeneration Ventures) portfolio company Brenig Therapeutics closed a $65 million Series A financing round led by NEA, with support from an…
Liked by Caroline Goddeeris
-
🍾 €60M Series B round for our portfolio company Confo Therapeutics This round is led by Ackermans & van Haaren together with Driehaus Capital…
🍾 €60M Series B round for our portfolio company Confo Therapeutics This round is led by Ackermans & van Haaren together with Driehaus Capital…
Liked by Caroline Goddeeris
-
📣👏 Kestra Medical Technologies, Inc. announced today an oversubscribed $196 million funding round to support the expansion of their commercial…
📣👏 Kestra Medical Technologies, Inc. announced today an oversubscribed $196 million funding round to support the expansion of their commercial…
Liked by Caroline Goddeeris
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Caroline Goddeeris
1 other named Caroline Goddeeris is on LinkedIn
See others named Caroline Goddeeris